CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
Simone Weber, Victoria Kehl, View ORCID ProfileJohanna Erber, Karolin I. Wagner, Ana-Marija Jetzlsperger, Theresa Burrell, Kilian Schober, Philipp Schommers, Max Augustin, Claudia S. Crowell, Markus Gerhard, Christof Winter, Christoph D. Spinner, View ORCID ProfileUlrike Protzer, Dieter Hoffmann, Elvira D’Ippolito, View ORCID ProfileDirk H Busch
doi: https://doi.org/10.1101/2021.12.22.21268268
Simone Weber
1Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
Victoria Kehl
2Institute for AI and Informatics in Medicine, School of Medicine, Technical University of Munich, Munich, Germany
Johanna Erber
3Department of Internal Medicine II, University Hospital Rechts Der Isar, School of Medicine, Technical University of Munich, Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
Karolin I. Wagner
1Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
Ana-Marija Jetzlsperger
4Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany
Theresa Burrell
1Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
Kilian Schober
5Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitäts-klinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, Germany
Philipp Schommers
6Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
7German Center for Infection Research (DZIF), partner site Bonn-Cologne, Germany
Max Augustin
6Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
7German Center for Infection Research (DZIF), partner site Bonn-Cologne, Germany
Claudia S. Crowell
1Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
Markus Gerhard
1Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
Christof Winter
9Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Germany
Christoph D. Spinner
3Department of Internal Medicine II, University Hospital Rechts Der Isar, School of Medicine, Technical University of Munich, Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
Ulrike Protzer
4Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany
Dieter Hoffmann
4Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany
Elvira D’Ippolito
1Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
Dirk H Busch
1Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted December 24, 2021.
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
Simone Weber, Victoria Kehl, Johanna Erber, Karolin I. Wagner, Ana-Marija Jetzlsperger, Theresa Burrell, Kilian Schober, Philipp Schommers, Max Augustin, Claudia S. Crowell, Markus Gerhard, Christof Winter, Christoph D. Spinner, Ulrike Protzer, Dieter Hoffmann, Elvira D’Ippolito, Dirk H Busch
medRxiv 2021.12.22.21268268; doi: https://doi.org/10.1101/2021.12.22.21268268
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
Simone Weber, Victoria Kehl, Johanna Erber, Karolin I. Wagner, Ana-Marija Jetzlsperger, Theresa Burrell, Kilian Schober, Philipp Schommers, Max Augustin, Claudia S. Crowell, Markus Gerhard, Christof Winter, Christoph D. Spinner, Ulrike Protzer, Dieter Hoffmann, Elvira D’Ippolito, Dirk H Busch
medRxiv 2021.12.22.21268268; doi: https://doi.org/10.1101/2021.12.22.21268268
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (707)
- Anesthesia (198)
- Cardiovascular Medicine (2904)
- Dermatology (249)
- Emergency Medicine (435)
- Epidemiology (12667)
- Forensic Medicine (10)
- Gastroenterology (820)
- Genetic and Genomic Medicine (4524)
- Geriatric Medicine (411)
- Health Economics (722)
- Health Informatics (2891)
- Health Policy (1062)
- Hematology (382)
- HIV/AIDS (917)
- Medical Education (421)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4283)
- Nursing (233)
- Nutrition (630)
- Oncology (2246)
- Ophthalmology (639)
- Orthopedics (257)
- Otolaryngology (324)
- Pain Medicine (274)
- Palliative Medicine (83)
- Pathology (492)
- Pediatrics (1188)
- Primary Care Research (491)
- Public and Global Health (6871)
- Radiology and Imaging (1510)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (481)
- Toxicology (60)
- Transplantation (207)
- Urology (177)